ZOMDF
Zomedica Corp.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies | Q1 2025 | Q2 2025 | → $0.06 | -52% |
| Citadel Advisors | Q3 2024 | Q4 2024 | → $0.14 | -11% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Zomedica Corp.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 26, 2026 — the most recent Form 4 on file — not from today.
- Form 40001654954-26-005315May 26, 2026
- Form 40001654954-26-005242May 21, 2026
- Form 40001654954-26-005241May 21, 2026
- Form 40001654954-26-004895May 14, 2026
- Form 40001654954-26-004668May 11, 2026
- Form 40001654954-26-004631May 8, 2026
- Form 40001654954-25-013229Nov 18, 2025
- Form 40001654954-25-013228Nov 18, 2025
- Form 40001654954-25-013227Nov 18, 2025
- Form 40001654954-25-013226Nov 18, 2025
- Form 40001654954-25-013225Nov 18, 2025
- Form 40001654954-25-013224Nov 18, 2025
- Form 40001654954-25-013223Nov 18, 2025
- Form 40001654954-25-013020Nov 14, 2025
- Form 40001654954-25-012794Nov 12, 2025
Fundamentals
XBRL · Zomedica Corp.Annual figures sourced directly from Zomedica Corp.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Zomedica Corp. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KMay 6, 2026
- 10-QQuarterly reportMay 6, 2026
- DEF 14AProxy statementApr 27, 2026
- 8-KFORM 8-KMar 16, 2026
- 10-KAnnual reportMar 16, 2026
- 8-KFORM 8-KNov 4, 2025
- 10-QQuarterly reportNov 4, 2025
- 8-KFORM 8-KAug 6, 2025
- 10-QQuarterly reportAug 6, 2025
- 8-KFORM 8-KJun 11, 2025
- 8-KFORM 8-KMay 15, 2025
- 10-QQuarterly reportMay 15, 2025
- DEF 14AProxy statementApr 30, 2025
- 8-KFORM 8-KApr 30, 2025
- 8-KFORM 8-KMar 14, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Renaissance Technologies | Q1 2025 | Q2 2025 | $0.12 | $0.06 | -52% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.16 | $0.14 | -11% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.